Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?
Werte in diesem Artikel
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large.On top of the Zacks Rank, investors can also look at our innovative Style Scores system to find stocks with specific traits. For example, value investors will want to focus on the "Value" category. Stocks with high Zacks Ranks and "A" grades for Value will be some of the highest-quality value stocks on the market today.One company value investors might notice is Fresenius Medical Care AG & Co. (FMS). FMS is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock holds a P/E ratio of 11.52, while its industry has an average P/E of 33.56. FMS's Forward P/E has been as high as 16.85 and as low as 10.51, with a median of 11.94, all within the past year.Investors should also note that FMS holds a PEG ratio of 0.93. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. FMS's industry currently sports an average PEG of 2.68. Over the past 52 weeks, FMS's PEG has been as high as 1.15 and as low as 0.82, with a median of 0.92.These figures are just a handful of the metrics value investors tend to look at, but they help show that Fresenius Medical Care AG & Co. Is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, FMS feels like a great value stock at the moment.Infrastructure Stock Boom to Sweep AmericaA massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.The only question is “Will you get into the right stocks early when their growth potential is greatest?”Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.Download FREE: How To Profit From Trillions On Spending For Infrastructure >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Fresenius Medical Care AG & Co. KGaA (FMS): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Fresenius Medical Care (FMC) St.
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Fresenius Medical Care (FMC) St.
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Fresenius SE & Co. KGaA (St.)
Analysen zu Fresenius SE & Co. KGaA (St.)
Datum | Rating | Analyst | |
---|---|---|---|
18.11.2024 | Fresenius SECo Buy | Warburg Research | |
11.11.2024 | Fresenius SECo Buy | Deutsche Bank AG | |
08.11.2024 | Fresenius SECo Neutral | Goldman Sachs Group Inc. | |
07.11.2024 | Fresenius SECo Buy | Deutsche Bank AG | |
07.11.2024 | Fresenius SECo Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
Datum | Rating | Analyst | |
---|---|---|---|
18.11.2024 | Fresenius SECo Buy | Warburg Research | |
11.11.2024 | Fresenius SECo Buy | Deutsche Bank AG | |
07.11.2024 | Fresenius SECo Buy | Deutsche Bank AG | |
07.11.2024 | Fresenius SECo Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.11.2024 | Fresenius SECo Overweight | JP Morgan Chase & Co. |
Datum | Rating | Analyst | |
---|---|---|---|
08.11.2024 | Fresenius SECo Neutral | Goldman Sachs Group Inc. | |
06.11.2024 | Fresenius SECo Neutral | Goldman Sachs Group Inc. | |
13.09.2024 | Fresenius SECo Neutral | Goldman Sachs Group Inc. | |
31.07.2024 | Fresenius SECo Neutral | Goldman Sachs Group Inc. | |
31.07.2024 | Fresenius SECo Neutral | JP Morgan Chase & Co. |
Datum | Rating | Analyst | |
---|---|---|---|
02.11.2021 | Fresenius SECo Underperform | Jefferies & Company Inc. | |
30.07.2021 | Fresenius SECo Underperform | Jefferies & Company Inc. | |
23.07.2021 | Fresenius SECo Underperform | Jefferies & Company Inc. | |
17.03.2021 | Fresenius SECo Underperform | Jefferies & Company Inc. | |
23.02.2021 | Fresenius SECo Underperform | Jefferies & Company Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius SE & Co. KGaA (St.) nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen